Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00129766
What this trial is testing

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 6,635
Not applicableStudy completedNCT01537198
What this trial is testing

Surveillance of Synagis in Korean Pediatric Patients

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 618
Large-scale testing (Phase 3)Ended earlyNCT06252285
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 6,300
Testing effectiveness (Phase 2)Ended earlyNCT03916185
What this trial is testing

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus (RSV)
National Institute of Allergy and Infectious Diseases (NIAID) 67
Early research (Phase 1)Study completedNCT04528719
What this trial is testing

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 651
Testing effectiveness (Phase 2)Ended earlyNCT03333317
What this trial is testing

Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 7
Testing effectiveness (Phase 2)Study completedNCT04690335
What this trial is testing

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

Who this might be right for
RSV Infection
Meissa Vaccines, Inc. 60
Not applicableStudy completedNCT01107535
What this trial is testing

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Abbott 82
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Not applicableNot Yet RecruitingNCT07643688
What this trial is testing

Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections

Who this might be right for
SARS CoV 2 InfectionRSV InfectionsInfluenza Infection
Fabiana Sherine Ganem dos Santos 150
Testing effectiveness (Phase 2)Study completedNCT04681833
What this trial is testing

Safety and Efficacy of BARS13 in the Elderly

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 125
Not applicableStudy completedNCT01995175
What this trial is testing

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Who this might be right for
Respiratory Syncytial Virus
GlaxoSmithKline 2,409
Not applicableStudy completedNCT06824207
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 2,400
Testing effectiveness (Phase 2)Study completedNCT04657198
What this trial is testing

Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 126
Early research (Phase 1)Active Not RecruitingNCT05743881
What this trial is testing

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Who this might be right for
Respiratory Syncytial VirusHuman Metapneumovirus
ModernaTX, Inc. 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128121
What this trial is testing

Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Shenzhen Shenxin Biotechnology Co., Ltd 500
Not applicableStudy completedNCT03629145
What this trial is testing

Music Therapy With Intubated and Sedated Pediatric Patients

Who this might be right for
Respiratory Syncytial Virus Infections
Children's Healthcare of Atlanta 33
Early research (Phase 1)Study completedNCT06847464
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Who this might be right for
RSV InfectionDrug Drug Interaction (DDI)
Enanta Pharmaceuticals, Inc 48
Early research (Phase 1)Study completedNCT04498741
What this trial is testing

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 89
Large-scale testing (Phase 3)Study completedNCT06083623
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 2,282
Next Page